Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 12 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2018 Filed Jun 6, 2018 17:28 UTC |
Kirson Eilon D.Chief Science Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 68,250 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001209191-18-036127 · doc4.xml · derivative · entry 10 Kirson Eilon D. · CIK 0001654356 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,750 Underlying: Ordinary Shares · 68,250 shares Expires 2027-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Options exercised were fully vested as of the date hereof. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 17:28 UTC |
Kirson Eilon D.Chief Science Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 59,130 | $0.00 Strike: $7.48 | $0.00 |
DisclosureSEC source: 0001209191-18-036127 · doc4.xml · derivative · entry 9 Kirson Eilon D. · CIK 0001654356 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 59,130 shares Expires 2024-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Options exercised were fully vested as of the date hereof. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 17:28 UTC |
Kirson Eilon D.Chief Science Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 218,781 | $0.00 Strike: $7.03 | $0.00 |
DisclosureSEC source: 0001209191-18-036127 · doc4.xml · derivative · entry 8 Kirson Eilon D. · CIK 0001654356 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 218,781 shares Expires 2023-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Options exercised were fully vested as of the date hereof. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 17:28 UTC |
Kirson Eilon D.Chief Science Officer
|
SaleOrdinary Shares | 4,131 | $31.74 | $131,117.94 |
DisclosureSEC source: 0001209191-18-036127 · doc4.xml · nonDerivative · entry 7 Kirson Eilon D. · CIK 0001654356 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,582 F4 · price: On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 4,131 shares in multiple trades at prices ranging from $31.00 to $31.99. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 17:28 UTC |
Kirson Eilon D.Chief Science Officer
|
SaleOrdinary Shares | 1,800 | $30.26 | $54,468.00 |
DisclosureSEC source: 0001209191-18-036127 · doc4.xml · nonDerivative · entry 6 Kirson Eilon D. · CIK 0001654356 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,713 F3 · price: On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 1,800 shares in multiple trades at prices ranging from $30.00 to $30.99. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 17:28 UTC |
Kirson Eilon D.Chief Science Officer
|
SaleOrdinary Shares | 114,934 | $29.36 | $3,374,462.24 |
DisclosureSEC source: 0001209191-18-036127 · doc4.xml · nonDerivative · entry 5 Kirson Eilon D. · CIK 0001654356 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,513 F2 · price: On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 114,934 shares in multiple trades at prices ranging from $29.00 to $29.99. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 17:28 UTC |
Kirson Eilon D.Chief Science Officer
|
Exercise / conversionOrdinary Shares | 68,250 | $7.15 | $487,987.50 |
DisclosureSEC source: 0001209191-18-036127 · doc4.xml · nonDerivative · entry 4 Kirson Eilon D. · CIK 0001654356 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,447 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 17:28 UTC |
Kirson Eilon D.Chief Science Officer
|
Exercise / conversionOrdinary Shares | 59,130 | $7.48 | $442,292.40 |
DisclosureSEC source: 0001209191-18-036127 · doc4.xml · nonDerivative · entry 3 Kirson Eilon D. · CIK 0001654356 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,197 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 17:28 UTC |
Kirson Eilon D.Chief Science Officer
|
SaleOrdinary Shares | 225,296 | $28.60 | $6,443,465.60 |
DisclosureSEC source: 0001209191-18-036127 · doc4.xml · nonDerivative · entry 2 Kirson Eilon D. · CIK 0001654356 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,067 F1 · price: On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 225,296 shares in multiple trades at prices ranging from $28.00 to $28.99. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 17:28 UTC |
Kirson Eilon D.Chief Science Officer
|
Exercise / conversionOrdinary Shares | 218,781 | $7.03 | $1,538,030.43 |
DisclosureSEC source: 0001209191-18-036127 · doc4.xml · nonDerivative · entry 1 Kirson Eilon D. · CIK 0001654356 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,363 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2018 Filed Jun 7, 2018 00:12 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 2,800 | $32.00 | $89,600.00 |
DisclosureSEC source: 0001209191-18-036187 · doc4.xml · nonDerivative · entry 5 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,820 F5 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger. Read SEC document |
| June 04, 2018 Filed Jun 7, 2018 00:12 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 19,694 | $31.64 | $623,118.16 |
DisclosureSEC source: 0001209191-18-036187 · doc4.xml · nonDerivative · entry 4 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,620 F4 · price: On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 19,694 shares in multiple trades at prices ranging from $31.00 to $31.975. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 04, 2018 Filed Jun 7, 2018 00:12 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 28,150 | $30.34 | $854,071.00 |
DisclosureSEC source: 0001209191-18-036187 · doc4.xml · nonDerivative · entry 3 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,314 F3 · price: On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 28,150 shares in multiple trades at prices ranging from $30.00 to $30.95. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 04, 2018 Filed Jun 7, 2018 00:12 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 26,782 | $29.31 | $784,980.42 |
DisclosureSEC source: 0001209191-18-036187 · doc4.xml · nonDerivative · entry 2 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,464 F2 · price: On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 26,782 shares in multiple trades at prices ranging from $29.00 to $29.95. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 04, 2018 Filed Jun 7, 2018 00:12 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 149,878 | $28.43 | $4,261,031.54 |
DisclosureSEC source: 0001209191-18-036187 · doc4.xml · nonDerivative · entry 1 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,246 F1 · price: On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 149,878 shares in multiple trades at prices ranging from $28.00 to $28.95. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 20:08 UTC |
PHILLIPS CHARLES G IIIDirector
|
GrantRestricted Stock Unit · Derivative | 6,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-035380 · doc4.xml · derivative · entry 2 PHILLIPS CHARLES G III · CIK 0001129246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,145 Underlying: Ordinary Shares · 6,145 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share. F3 · derivative.exercise_date: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. F3 · derivative.expiration_date: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 20:08 UTC |
PHILLIPS CHARLES G IIIDirector
|
GrantOptions to Buy Ordinary Shares · Derivative | 12,345 | $0.00 Strike: $31.45 | $0.00 |
DisclosureSEC source: 0001209191-18-035380 · doc4.xml · derivative · entry 1 PHILLIPS CHARLES G III · CIK 0001129246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,345 Underlying: Ordinary Shares · 12,345 shares Expires 2028-05-31 F1 · derivative.exercise_date: Options to buy 12,345 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 20:12 UTC |
Burkoth William T.Director
|
GrantRestricted Stock Unit · Derivative | 6,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-035383 · doc4.xml · derivative · entry 2 Burkoth William T. · CIK 0001654261 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,145 Underlying: Ordinary Shares · 6,145 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share. F3 · derivative.exercise_date: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. F3 · derivative.expiration_date: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 20:12 UTC |
Burkoth William T.Director
|
GrantOptions to Buy Ordinary Shares · Derivative | 12,345 | $0.00 Strike: $31.45 | $0.00 |
DisclosureSEC source: 0001209191-18-035383 · doc4.xml · derivative · entry 1 Burkoth William T. · CIK 0001654261 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,345 Underlying: Ordinary Shares · 12,345 shares Expires 2028-05-31 F1 · derivative.exercise_date: Options to buy 12,345 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. Read SEC document |
| May 31, 2018 Filed Jun 5, 2018 01:42 UTC |
Hung DavidDirector
|
GrantOptions to Buy Ordinary Shares · Derivative | 45,137 | $0.00 Strike: $31.45 | $0.00 |
DisclosureSEC source: 0001209191-18-035427 · doc4.xml · derivative · entry 1 Hung David · CIK 0001310880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,137 Underlying: Ordinary Shares · 45,137 shares Expires 2028-05-31 F1 · derivative.exercise_date: This stock option will vest in equal parts on the earlier of each of the following dates: (i) the first, second and third anniversary of the grant date and (ii) the day immediately preceding of the Company's 2019, 2020 and 2021 annual general meeting of shareholders, respectively. Read SEC document |
| May 31, 2018 Filed Jun 5, 2018 00:17 UTC |
McCoy Sherilyn SDirector
|
GrantOptions to Buy Ordinary Shares · Derivative | 45,137 | $0.00 Strike: $31.45 | $0.00 |
DisclosureSEC source: 0001209191-18-035384 · doc4.xml · derivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,137 Underlying: Ordinary Shares · 45,137 shares Expires 2028-05-31 F1 · derivative.exercise_date: This stock option will vest in equal parts on the earlier of each of the following dates: (i) the first, second and third anniversary of the grant date and (ii) the day immediately preceding of the Company's 2019, 2020 and 2021 annual general meeting of shareholders, respectively. Read SEC document |
| May 31, 2018 Filed Jun 5, 2018 00:10 UTC |
Madden Martin J.Director
|
GrantRestricted Stock Unit · Derivative | 8,906 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-035382 · doc4.xml · derivative · entry 2 Madden Martin J. · CIK 0001696864 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,906 Underlying: Ordinary Shares · 8,906 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share. F3 · derivative.exercise_date: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. F3 · derivative.expiration_date: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. Read SEC document |
| May 31, 2018 Filed Jun 5, 2018 00:10 UTC |
Madden Martin J.Director
|
GrantOptions to Buy Ordinary Shares · Derivative | 17,891 | $0.00 Strike: $31.45 | $0.00 |
DisclosureSEC source: 0001209191-18-035382 · doc4.xml · derivative · entry 1 Madden Martin J. · CIK 0001696864 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,891 Underlying: Ordinary Shares · 17,891 shares Expires 2028-05-31 F1 · derivative.exercise_date: Options to buy 17,891 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. Read SEC document |
| May 31, 2018 Filed Jun 5, 2018 00:07 UTC |
LAVIGNE LOUIS J JRDirector
|
GrantRestricted Stock Unit · Derivative | 6,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-035379 · doc4.xml · derivative · entry 2 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,145 Underlying: Ordinary Shares · 6,145 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share. F3 · derivative.exercise_date: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. F3 · derivative.expiration_date: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. Read SEC document |
| May 31, 2018 Filed Jun 5, 2018 00:07 UTC |
LAVIGNE LOUIS J JRDirector
|
GrantOptions to Buy Ordinary Shares · Derivative | 12,345 | $0.00 Strike: $31.45 | $0.00 |
DisclosureSEC source: 0001209191-18-035379 · doc4.xml · derivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,345 Underlying: Ordinary Shares · 12,345 shares Expires 2028-05-31 F1 · derivative.exercise_date: Options to buy 12,345 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. Read SEC document |
| May 31, 2018 Filed Jun 5, 2018 00:09 UTC |
VERNON W ANTHONYDirector
|
GrantRestricted Stock Unit · Derivative | 6,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-035381 · doc4.xml · derivative · entry 2 VERNON W ANTHONY · CIK 0001369091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,145 Underlying: Ordinary Shares · 6,145 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share. F3 · derivative.exercise_date: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. F3 · derivative.expiration_date: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. Read SEC document |
| May 31, 2018 Filed Jun 5, 2018 00:09 UTC |
VERNON W ANTHONYDirector
|
GrantOptions to Buy Ordinary Shares · Derivative | 12,345 | $0.00 Strike: $31.45 | $0.00 |
DisclosureSEC source: 0001209191-18-035381 · doc4.xml · derivative · entry 1 VERNON W ANTHONY · CIK 0001369091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,345 Underlying: Ordinary Shares · 12,345 shares Expires 2028-05-31 F1 · derivative.exercise_date: Options to buy 12,345 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. Read SEC document |
| May 31, 2018 Filed Jun 5, 2018 00:05 UTC |
LEUNG GABRIELDirector
|
GrantRestricted Stock Unit · Derivative | 6,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-035378 · doc4.xml · derivative · entry 2 LEUNG GABRIEL · CIK 0001236183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,145 Underlying: Ordinary Shares · 6,145 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share. F3 · derivative.exercise_date: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. F3 · derivative.expiration_date: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. Read SEC document |
| May 31, 2018 Filed Jun 5, 2018 00:05 UTC |
LEUNG GABRIELDirector
|
GrantOptions to Buy Ordinary Shares · Derivative | 12,345 | $0.00 Strike: $31.45 | $0.00 |
DisclosureSEC source: 0001209191-18-035378 · doc4.xml · derivative · entry 1 LEUNG GABRIEL · CIK 0001236183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,345 Underlying: Ordinary Shares · 12,345 shares Expires 2028-05-31 F1 · derivative.exercise_date: Options to buy 12,345 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. Read SEC document |
| May 25, 2018 Filed May 30, 2018 18:01 UTC |
PHILLIPS CHARLES G IIIDirector
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 50,000 | $0.00 Strike: $6.72 | $0.00 |
DisclosureSEC source: 0001209191-18-034229 · doc4.xml · derivative · entry 3 PHILLIPS CHARLES G III · CIK 0001129246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,607 Underlying: Ordinary Shares · 50,000 shares Expires 2022-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options to buy 50,000 ordinary shares are vested and currently exercisable as of the date hereof. Read SEC document |
| May 25, 2018 Filed May 30, 2018 18:01 UTC |
PHILLIPS CHARLES G IIIDirector
|
SaleOrdinary Shares | 50,000 | $30.30 | $1,515,075.00 |
DisclosureSEC source: 0001209191-18-034229 · doc4.xml · nonDerivative · entry 2 PHILLIPS CHARLES G III · CIK 0001129246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: On May 25, 2018, Mr. Phillips sold 50,000 shares in multiple trades at prices ranging from $30.125 to $30.625. The price reported above reflects the weighted average sale price. Mr. Phillips hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 25, 2018 Filed May 30, 2018 18:01 UTC |
PHILLIPS CHARLES G IIIDirector
|
Exercise / conversionOrdinary Shares | 50,000 | $6.72 | $336,000.00 |
DisclosureSEC source: 0001209191-18-034229 · doc4.xml · nonDerivative · entry 1 PHILLIPS CHARLES G III · CIK 0001129246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2018 Filed May 17, 2018 20:18 UTC |
LEUNG GABRIELDirector
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 100,000 | $0.00 Strike: $3.44 | $0.00 |
DisclosureSEC source: 0001209191-18-030889 · doc4.xml · derivative · entry 6 LEUNG GABRIEL · CIK 0001236183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,743 Underlying: Ordinary Shares · 100,000 shares Expires 2021-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Options to buy 100,000 ordinary shares are vested and currently exercisable as of the date hereof. Read SEC document |
| May 16, 2018 Filed May 17, 2018 20:18 UTC |
LEUNG GABRIELDirector
|
SaleOrdinary Shares | 40,000 | $28.77 | $1,150,800.00 |
DisclosureSEC source: 0001209191-18-030889 · doc4.xml · nonDerivative · entry 4 LEUNG GABRIEL · CIK 0001236183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 F2 · price: On May 16, 2018, Mr. Leung sold 40,000 shares in multiple trades at prices ranging from $28.65 to $28.94. The price reported above reflects the weighted average sale price. Mr. Leung hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 16, 2018 Filed May 17, 2018 20:18 UTC |
LEUNG GABRIELDirector
|
Exercise / conversionOrdinary Shares | 100,000 | $3.44 | $344,000.00 |
DisclosureSEC source: 0001209191-18-030889 · doc4.xml · nonDerivative · entry 3 LEUNG GABRIEL · CIK 0001236183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2018 Filed May 17, 2018 20:18 UTC |
LEUNG GABRIELDirector
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 40,000 | $0.00 Strike: $3.44 | $0.00 |
DisclosureSEC source: 0001209191-18-030889 · doc4.xml · derivative · entry 5 LEUNG GABRIEL · CIK 0001236183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,743 Underlying: Ordinary Shares · 40,000 shares Expires 2021-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options to buy 40,000 ordinary shares are vested and currently exercisable as of the date hereof. Read SEC document |
| May 15, 2018 Filed May 17, 2018 20:18 UTC |
LEUNG GABRIELDirector
|
SaleOrdinary Shares | 40,000 | $28.88 | $1,155,200.00 |
DisclosureSEC source: 0001209191-18-030889 · doc4.xml · nonDerivative · entry 2 LEUNG GABRIEL · CIK 0001236183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: On May 15, 2018, Mr. Leung sold 40,000 shares in multiple trades at prices ranging from $28.80 to $28.98. The price reported above reflects the weighted average sale price. Mr. Leung hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 15, 2018 Filed May 17, 2018 20:18 UTC |
LEUNG GABRIELDirector
|
Exercise / conversionOrdinary Shares | 40,000 | $3.44 | $137,600.00 |
DisclosureSEC source: 0001209191-18-030889 · doc4.xml · nonDerivative · entry 1 LEUNG GABRIEL · CIK 0001236183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2018 Filed May 15, 2018 20:26 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 280 | $30.25 | $8,470.00 |
DisclosureSEC source: 0001209191-18-030229 · doc4.xml · nonDerivative · entry 10 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,121 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| May 14, 2018 Filed May 15, 2018 20:26 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 200 | $30.23 | $6,045.00 |
DisclosureSEC source: 0001209191-18-030229 · doc4.xml · nonDerivative · entry 9 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,401 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| May 14, 2018 Filed May 15, 2018 20:26 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 200 | $30.20 | $6,040.00 |
DisclosureSEC source: 0001209191-18-030229 · doc4.xml · nonDerivative · entry 8 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,601 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| May 14, 2018 Filed May 15, 2018 20:26 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 1,772 | $30.15 | $53,425.80 |
DisclosureSEC source: 0001209191-18-030229 · doc4.xml · nonDerivative · entry 7 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,801 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| May 14, 2018 Filed May 15, 2018 20:26 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 4,927 | $30.10 | $148,302.70 |
DisclosureSEC source: 0001209191-18-030229 · doc4.xml · nonDerivative · entry 6 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,573 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| May 14, 2018 Filed May 15, 2018 20:26 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 100 | $30.08 | $3,007.50 |
DisclosureSEC source: 0001209191-18-030229 · doc4.xml · nonDerivative · entry 5 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,500 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| May 14, 2018 Filed May 15, 2018 20:26 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 3,590 | $30.05 | $107,879.50 |
DisclosureSEC source: 0001209191-18-030229 · doc4.xml · nonDerivative · entry 4 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,600 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| May 14, 2018 Filed May 15, 2018 20:26 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 10,008 | $30.00 | $300,240.00 |
DisclosureSEC source: 0001209191-18-030229 · doc4.xml · nonDerivative · entry 3 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,190 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| May 11, 2018 Filed May 15, 2018 20:26 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 2,700 | $30.03 | $81,067.50 |
DisclosureSEC source: 0001209191-18-030229 · doc4.xml · nonDerivative · entry 2 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,198 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| May 11, 2018 Filed May 15, 2018 20:26 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 6,693 | $30.00 | $200,790.00 |
DisclosureSEC source: 0001209191-18-030229 · doc4.xml · nonDerivative · entry 1 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,898 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen. Read SEC document |
| May 09, 2018 Filed May 10, 2018 20:12 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
Tax withholdingOrdinary Shares | 28,652 | $28.26 | $809,619.56 |
DisclosureSEC source: 0000899243-18-012335 · doc4.xml · nonDerivative · entry 2 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 912,143 F1 · shares: 293,840 restricted stock units ("RSUs") vested on May 2, 2018. The issuer released one-fifth of the RSUs (58,768 RSUs) as of May 3, 2018 (previously reported on a Form 4 filed on May 4, 2018), released one-fifth of the RSUs as of May 4, 2018 and one-fifth of the RSUs as of May 7, 2018 (previously reported on a Form 4 filed on May 8, 2018), and released an additional one-fifth of the RSUs as of May 8, 2018 and one-fifth of the RSUs as of May 9, 2018. Mr. Doyle has sold sufficient RSUs to cover the tax liability. One-half of the remaining RSUs is scheduled to vest on each of May 2, 2019 and May 2, 2020, subject to Mr. Doyle's continued employment through such dates, pursuant to his Restricted Share Unit Award Notice with NovoCure Limited, dated as of May 2, 2017. F2 · shares: Represents the sale of shares to cover tax withholding obligations in connection with the settlement and release of fully-vested restricted stock units ("RSUs") granted by the issuer to the reporting person and reported on a Form 4 filed on May 4, 2017. Read SEC document |
| May 08, 2018 Filed May 10, 2018 20:12 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
Tax withholdingOrdinary Shares | 28,756 | $28.06 | $806,749.58 |
DisclosureSEC source: 0000899243-18-012335 · doc4.xml · nonDerivative · entry 1 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 940,795 F1 · shares: 293,840 restricted stock units ("RSUs") vested on May 2, 2018. The issuer released one-fifth of the RSUs (58,768 RSUs) as of May 3, 2018 (previously reported on a Form 4 filed on May 4, 2018), released one-fifth of the RSUs as of May 4, 2018 and one-fifth of the RSUs as of May 7, 2018 (previously reported on a Form 4 filed on May 8, 2018), and released an additional one-fifth of the RSUs as of May 8, 2018 and one-fifth of the RSUs as of May 9, 2018. Mr. Doyle has sold sufficient RSUs to cover the tax liability. One-half of the remaining RSUs is scheduled to vest on each of May 2, 2019 and May 2, 2020, subject to Mr. Doyle's continued employment through such dates, pursuant to his Restricted Share Unit Award Notice with NovoCure Limited, dated as of May 2, 2017. F2 · shares: Represents the sale of shares to cover tax withholding obligations in connection with the settlement and release of fully-vested restricted stock units ("RSUs") granted by the issuer to the reporting person and reported on a Form 4 filed on May 4, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.